hrcak mascot   Srce   HID

Other

Topical 5% benzoyl peroxide and 3% erythromycin gel: Experience from 191 patients with inflammatory acne

Efstathios Andreas Rallis ; Veterans Administration Hospital (NIMTS), Department of Dermatology
Constantinos Verros
Alexandros Katoulis
Alexandra Katsarou

Fulltext: english, PDF (307 KB) pages 160-160 downloads: 720* cite
APA 6th Edition
Andreas Rallis, E., Verros, C., Katoulis, A. & Katsarou, A. (2013). Topical 5% benzoyl peroxide and 3% erythromycin gel: Experience from 191 patients with inflammatory acne. Acta Dermatovenerologica Croatica, 21 (3), 160-160. Retrieved from https://hrcak.srce.hr/109922
MLA 8th Edition
Andreas Rallis, Efstathios, et al. "Topical 5% benzoyl peroxide and 3% erythromycin gel: Experience from 191 patients with inflammatory acne." Acta Dermatovenerologica Croatica, vol. 21, no. 3, 2013, pp. 160-160. https://hrcak.srce.hr/109922. Accessed 6 Dec. 2021.
Chicago 17th Edition
Andreas Rallis, Efstathios, Constantinos Verros, Alexandros Katoulis and Alexandra Katsarou. "Topical 5% benzoyl peroxide and 3% erythromycin gel: Experience from 191 patients with inflammatory acne." Acta Dermatovenerologica Croatica 21, no. 3 (2013): 160-160. https://hrcak.srce.hr/109922
Harvard
Andreas Rallis, E., et al. (2013). 'Topical 5% benzoyl peroxide and 3% erythromycin gel: Experience from 191 patients with inflammatory acne', Acta Dermatovenerologica Croatica, 21(3), pp. 160-160. Available at: https://hrcak.srce.hr/109922 (Accessed 06 December 2021)
Vancouver
Andreas Rallis E, Verros C, Katoulis A, Katsarou A. Topical 5% benzoyl peroxide and 3% erythromycin gel: Experience from 191 patients with inflammatory acne. Acta Dermatovenerol Croat. [Internet]. 2013 [cited 2021 December 06];21(3):160-160. Available from: https://hrcak.srce.hr/109922
IEEE
E. Andreas Rallis, C. Verros, A. Katoulis and A. Katsarou, "Topical 5% benzoyl peroxide and 3% erythromycin gel: Experience from 191 patients with inflammatory acne", Acta Dermatovenerologica Croatica, vol.21, no. 3, pp. 160-160, 2013. [Online]. Available: https://hrcak.srce.hr/109922. [Accessed: 06 December 2021]

Abstracts
Background. A dramatic increase in bacterial resistance as a result of the use of topical antibiotics in acne has been recorded over the past 20 years.
Aim. In this study we investigated the efficacy and safety of the topical treatment with 5% benzoyl peroxide and 3% erythromycin gel in patients with inflammatory acne.
Materials and Methods. One hundred and ninety one patients with inflammatory acne were evaluated. The patients included 54 males and 137 females with a mean average age being 22.3±8.1 years. The topical gel was applied on the face, once daily, for 3 months.
Results. The mean number of non-inflammatory and inflammatory decreased. These findings were statistically significant from baseline with a mean percentage reduction of the non-inflammatory and inflammatory lesions, corresponding to 42.2% and 57.5% respectively.
Conclusion. Topical 5% benzoyl peroxide and erythromycin 3% as monotherapy is efficient in the treatment of inflammatory acne.

Keywords
Acne; inflammatory; treatment; topical treatment; 5% benzoyl peroxide gel; erythromycin 3% gel; antibiotics

Hrčak ID: 109922

URI
https://hrcak.srce.hr/109922

Visits: 1.095 *